Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1540, 2006-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Trastuzumab combo questions use of doxorubicin in breast cancer
Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. :
Access to resources
Recommend
Ceftobiprole keeps cSSTIs under control
Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. :
Novel triple combo provides added benefit in advanced breast cancer
Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. :
Bevacizumab: further evidence of risks in breast cancer patients
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :
Bevacizumab puts the brakes on breast cancer growth . . .
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :